Voyager Therapeutics, which is developing treatments for central nervous system diseases, has raised $124m from investors including Aventis.

The Roche-backed oncology treatment developer floated below its range in an IPO in which Pfizer and Bristol-Myers Squibb both acquired shares.

The Samsung-backed flash storage technology provider will float at the middle of the IPO's range, and could potentially raise up to $489m.

The Pfizer, Baxter and Celgene-backed oncology company will raise $43.7m from an initial public offering where the share price was effectively halved in the space of two weeks.

The cardiovascular-focused pharmaceutical company has raised $94m in equity from investors including strategic partner Sanofi.

Pfizer and Bristol-Myers Squibb will buy a combined $15m of stock in the immuno-oncology drug developer through the offering.

The flash storage company, backed by Samsung, has set the range for its initial public offering at $16 to $18 per share, expecting to raise up to $450m.

ProSiebenSat.1 and Access Industries-backed music streaming service Deezer is set to float on the Paris stock exchange by the end of the year.

Novartis-backed Nabriva has floated on Nasdaq, raising the amount of proceeds it expected when it filed in June 2015.

GlaxoSmithKline-backed RegenXBio filed for its initial public offering last month when it expected to raise up to $100m.